Market Overview

Benzinga's Top Upgrades, Downgrades For September 12, 2019

Share:

Upgrades

  • UBS upgraded the stock for AbbVie Inc (NYSE: ABBV) from Neutral to Buy. AbbVie earned $2.26 in the second quarter, compared to $2.00 in the year-ago quarter. The current market cap for AbbVie is at $67.5 billion. The stock has a 52-week-high of $96.60 and a 52-week-low of $62.66. AbbVie's stock last closed at $69.52 per share.
  • Barclays upgraded the stock for Analog Devices Inc (NASDAQ: ADI) from Equal-Weight to Overweight. Analog Devices earned $1.26 in the third quarter, compared to $1.53 in the year-ago quarter. The stock has a 52-week-high of $124.78 and a 52-week-low of $76.62. Analog Devices's stock last closed at $115.04 per share.
  • Nomura changed the rating for Activision Blizzard Inc (NASDAQ: ATVI) from Neutral to Buy. In the second quarter, Activision Blizzard showed an EPS of $0.38, compared to $0.41 from the year-ago quarter. The total market value of Activision Blizzard's outstanding shares is at $24.9 billion. The stock has a 52-week-high of $84.68 and a 52-week-low of $39.85. Activision Blizzard's stock last closed at $54.91 per share.
  • JP Morgan changed the rating for Franklin Resources Inc (NYSE: BEN) from Underweight to Neutral. For the third quarter, Franklin Resources had an EPS of $0.65, compared to year-ago quarter EPS of $0.75. The current market cap for Franklin Resources is at $15.3 billion. The stock has a 52-week-high of $35.82 and a 52-week-low of $25.57. Franklin Resources's stock last closed at $29.49 per share.
  • For Blueprint Medicines Corp (NASDAQ: BPMC), Raymond James upgraded the stock from Market Perform to Outperform. For the second quarter, Blueprint Medicines had an EPS of ($2.04), compared to year-ago quarter EPS of ($0.62). The total market value of Blueprint Medicines's outstanding shares is at $487.4 million. The stock has a 52-week-high of $102.98 and a 52-week-low of $44.58. Blueprint Medicines's stock last closed at $76.82 per share.
  • JP Morgan upgraded the stock for ChemoCentryx Inc (NASDAQ: CCXI) from Neutral to Overweight. ChemoCentryx earned ($0.26) in the second quarter, compared to ($0.14) in the year-ago quarter. ChemoCentryx's market cap stands at $379.7 million. The stock has a 52-week-high of $14.98 and a 52-week-low of $6.16. ChemoCentryx's stock last closed at $7.70 per share.
  • Wells Fargo changed the rating for C&J Energy Services Inc (NYSE: CJ) from Market Perform to Outperform. C&J Energy Services earned ($0.20) in the second quarter, compared to $0.51 in the year-ago quarter. The stock has a 52-week-high of $23.23 and a 52-week-low of $8.55. C&J Energy Services's stock last closed at $11.04 per share.
  • HSBC upgraded the stock for Ecopetrol SA (NYSE: EC) from Hold to Buy. In the second quarter, Ecopetrol showed an EPS of $0.49, compared to $0.56 from the year-ago quarter. Ecopetrol's market cap stands at $69.2 billion. The stock has a 52-week-high of $27.96 and a 52-week-low of $15.21. Ecopetrol's stock last closed at $17.08 per share.
  • UBS upgraded the stock for Embraer SA (NYSE: ERJ) from Neutral to Buy. In the second quarter, Embraer earned ($0.08). The stock has a 52-week-high of $23.68 and a 52-week-low of $16.73. Embraer's stock last closed at $18.44 per share.
  • JP Morgan upgraded the stock for Genmab A/S (NASDAQ: GMAB) from Neutral to Overweight. Genmab earned $0.20 in the second quarter. The stock has a 52-week-high of $21.45 and a 52-week-low of $12.10. Genmab's stock last closed at $19.89 per share.
  • Bernstein changed the rating for iQIYI Inc (NASDAQ: IQ) from Underperform to Market Perform. In the second quarter, iQIYI showed an EPS of ($0.49), compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $30.90 and a 52-week-low of $14.35. iQIYI's stock last closed at $19.32 per share.
  • For Kaman Corp (NYSE: KAMN), KeyBanc upgraded the stock from Sector Weight to Overweight. In the second quarter, Kaman showed an EPS of $0.16, compared to $0.54 from the year-ago quarter. Kaman's market cap stands at $1.5 billion. The stock has a 52-week-high of $68.79 and a 52-week-low of $51.34. Kaman's stock last closed at $62.09 per share.

 

Downgrades

  • UBS downgraded the stock for Adient PLC (NYSE: ADNT) from Buy to Neutral. In the third quarter, Adient showed an EPS of $0.38, compared to $1.45 from the year-ago quarter. The current market cap for Adient is at $2.2 billion. The stock has a 52-week-high of $45.17 and a 52-week-low of $12.14. Adient's stock last closed at $25.89 per share.
  • Wells Fargo changed the rating for Caterpillar Inc (NYSE: CAT) from Outperform to Market Perform. In the second quarter, Caterpillar showed an EPS of $2.83, compared to $2.97 from the year-ago quarter. The current market cap for Caterpillar is at $79.7 billion. The stock has a 52-week-high of $159.37 and a 52-week-low of $111.75. Caterpillar's stock last closed at $133.07 per share.
  • Wells Fargo downgraded the stock for Deere & Co (NYSE: DE) from Outperform to Market Perform. In the third quarter, Deere showed an EPS of $2.71, compared to $2.59 from the year-ago quarter. The current market cap for Deere is at $52.2 billion. The stock has a 52-week-high of $171.22 and a 52-week-low of $128.32. Deere's stock last closed at $165.15 per share.
  • Wells Fargo changed the rating for Helmerich & Payne Inc (NYSE: HP) from Outperform to Underperform. For the third quarter, Helmerich & Payne had an EPS of $0.41, compared to year-ago quarter EPS of ($0.01). The stock has a 52-week-high of $73.74 and a 52-week-low of $36.06. Helmerich & Payne's stock last closed at $42.66 per share.
  • Bernstein downgraded the stock for The Hershey Co (NYSE: HSY) from Outperform to Market Perform. Hershey earned $1.31 in the second quarter, compared to $1.14 in the year-ago quarter. The total market value of Hershey's outstanding shares is at $8.0 billion. The stock has a 52-week-high of $162.20 and a 52-week-low of $99.15. Hershey's stock last closed at $151.11 per share.
  • JP Morgan downgraded the stock for Invesco Ltd (NYSE: IVZ) from Overweight to Neutral. In the second quarter, Invesco showed an EPS of $0.65, compared to $0.66 from the year-ago quarter. The total market value of Invesco's outstanding shares is at $8.0 billion. The stock has a 52-week-high of $24.88 and a 52-week-low of $15.15. Invesco's stock last closed at $17.56 per share.
  • UBS changed the rating for Lear Corp (NYSE: LEA) from Buy to Neutral. In the second quarter, Lear showed an EPS of $3.78, compared to $4.95 from the year-ago quarter. The stock has a 52-week-high of $167.86 and a 52-week-low of $105.10. Lear's stock last closed at $126.40 per share.
  • For MRC Global Inc (NYSE: MRC), Cowen & Co. downgraded the stock from Outperform to Market Perform. In the second quarter, MRC Global showed an EPS of $0.20, compared to $0.17 from the year-ago quarter. The current market cap for MRC Global is at $1.4 billion. The stock has a 52-week-high of $19.91 and a 52-week-low of $11.19. MRC Global's stock last closed at $13.74 per share.
  • Raymond James downgraded the stock for MSC Industrial Direct Co Inc (NYSE: MSM) from Outperform to Market Perform. For the third quarter, MSC Industrial Direct Co had an EPS of $1.45, compared to year-ago quarter EPS of $1.39. The current market cap for MSC Industrial Direct Co is at $3.6 billion. The stock has a 52-week-high of $90.25 and a 52-week-low of $64.59. MSC Industrial Direct Co's stock last closed at $74.16 per share.
  • For Nabors Industries Ltd (NYSE: NBR), Wells Fargo downgraded the stock from Market Perform to Underperform. In the second quarter, Nabors Industries showed an EPS of ($0.41), compared to ($0.39) from the year-ago quarter. The current market cap for Nabors Industries is at $4.2 billion. The stock has a 52-week-high of $6.65 and a 52-week-low of $1.60. Nabors Industries's stock last closed at $2.42 per share.
  • Credit Suisse downgraded the stock for Nexa Resources SA (NYSE: NEXA) from Outperform to Neutral. Nexa Resources earned $0.15 in the second quarter, compared to ($0.30) in the year-ago quarter. Nexa Resources's market cap stands at $1.4 billion. The stock has a 52-week-high of $13.69 and a 52-week-low of $7.00. Nexa Resources's stock last closed at $9.52 per share.
  • For Nine Energy Service Inc (NYSE: NINE), Wells Fargo downgraded the stock from Outperform to Market Perform. In the second quarter, Nine Energy Service showed an EPS of $0.30, compared to $0.37 from the year-ago quarter. The current market cap for Nine Energy Service is at $619.6 million. The stock has a 52-week-high of $40.39 and a 52-week-low of $4.85. Nine Energy Service's stock last closed at $6.79 per share.
  • For Oil States International Inc (NYSE: OIS), Wells Fargo downgraded the stock from Outperform to Market Perform. In the second quarter, Oil States International showed an EPS of ($0.14), compared to $0.05 from the year-ago quarter. The current market cap for Oil States International is at $814.4 million. The stock has a 52-week-high of $34.66 and a 52-week-low of $11.73. Oil States International's stock last closed at $15.68 per share.
  • Susquehanna downgraded the stock for Universal Display Corp (NASDAQ: OLED) from Neutral to Negative. Interestingly, in the second quarter, Universal Display's EPS was $0.92. The current market cap for Universal Display is at $9.1 billion. The stock has a 52-week-high of $230.32 and a 52-week-low of $78.78. Universal Display's stock last closed at $193.16 per share.

 

Initiations

  • Deutsche Bank initiated coverage on AmerisourceBergen Corp (NYSE: ABC) with a Hold rating. The price target for AmerisourceBergen is set at $91.00. AmerisourceBergen earned $1.76 in the third quarter, compared to $1.54 in the year-ago quarter. The stock has a 52-week-high of $94.85 and a 52-week-low of $69.36. AmerisourceBergen's stock last closed at $87.79 per share.
  • BTIG initiated coverage on ACI Worldwide Inc (NASDAQ: ACIW) with a Buy rating. The price target for ACI Worldwide is set at $40.00. ACI Worldwide earned $0.05 in the second quarter, compared to ($0.13) in the year-ago quarter. The current market cap for ACI Worldwide is at $1.7 billion. The stock has a 52-week-high of $35.86 and a 52-week-low of $24.02. ACI Worldwide's stock last closed at $31.96 per share.
  • BMO Capital initiated coverage on Agios Pharmaceuticals Inc (NASDAQ: AGIO) with an Outperform rating. The price target for Agios Pharmaceuticals is set at $45.00. Agios Pharmaceuticals earned ($1.87) in the second quarter, compared to ($1.19) in the year-ago quarter. Agios Pharmaceuticals's market cap stands at $4.4 billion. The stock has a 52-week-high of $79.17 and a 52-week-low of $33.17. Agios Pharmaceuticals's stock last closed at $37.90 per share.
  • With a rating of Buy, Bank of America initiated coverage on Albany International Corp (NYSE: AIN). The price target is set at $99.00 for Albany International. For the second quarter, Albany International had an EPS of $1.09, compared to year-ago quarter EPS of $0.82. The current market cap for Albany International is at $2.6 billion. The stock has a 52-week-high of $87.71 and a 52-week-low of $58.06. Albany International's stock last closed at $87.56 per share.
  • With a rating of Outperform, BMO Capital initiated coverage on Alexion Pharmaceuticals Inc (NASDAQ: ALXN). The price target is set at $149.00 for Alexion Pharmaceuticals. For the second quarter, Alexion Pharmaceuticals had an EPS of $2.64, compared to year-ago quarter EPS of $2.07. The total market value of Alexion Pharmaceuticals's outstanding shares is at $24.1 billion. The stock has a 52-week-high of $141.86 and a 52-week-low of $92.56. Alexion Pharmaceuticals's stock last closed at $108.90 per share.
  • Guggenheim initiated coverage on Amneal Pharmaceuticals Inc (NYSE: AMRX) with a Sell rating. The price target for Amneal Pharmaceuticals is set at $2.50. In the second quarter, Amneal Pharmaceuticals showed an EPS of $0.09, compared to $0.24 from the year-ago quarter. Amneal Pharmaceuticals's market cap stands at $4.8 billion. The stock has a 52-week-high of $24.35 and a 52-week-low of $2.27. Amneal Pharmaceuticals's stock last closed at $3.46 per share.
  • Guggenheim initiated coverage on ANI Pharmaceuticals Inc (NASDAQ: ANIP) with a Buy rating. The price target for ANI Pharmaceuticals is set at $76.00. ANI Pharmaceuticals earned $1.44 in the second quarter, compared to $1.13 in the year-ago quarter. ANI Pharmaceuticals's market cap stands at $783.1 million. The stock has a 52-week-high of $86.96 and a 52-week-low of $36.92. ANI Pharmaceuticals's stock last closed at $69.64 per share.
  • Deutsche Bank initiated coverage on Anthem Inc (NYSE: ANTM) with a Buy rating. Anthem earned $4.64 in the second quarter, compared to $4.25 in the year-ago quarter. Anthem's market cap stands at $22.2 billion. The stock has a 52-week-high of $317.99 and a 52-week-low of $227.16. Anthem's stock last closed at $249.88 per share.
  • Wedbush initiated coverage on Aptinyx Inc (NASDAQ: APTX) with an Outperform rating. The price target for Aptinyx is set at $7.00. In the second quarter, Aptinyx earned ($0.36). The total market value of Aptinyx's outstanding shares is at $112.0 million. The stock has a 52-week-high of $32.25 and a 52-week-low of $2.88. Aptinyx's stock last closed at $4.08 per share.
  • BMO Capital initiated coverage on Arvinas Inc (NASDAQ: ARVN) with an Outperform rating. The price target for Arvinas is set at $34.00. Arvinas earned ($0.55) in the second quarter. The stock has a 52-week-high of $28.25 and a 52-week-low of $10.19. Arvinas's stock last closed at $24.63 per share.
  • Guggenheim Securities initiated coverage on Bausch Health Companies Inc (NYSE: BHC) with a Buy rating. The price target for Bausch Health Companies is set at $30.00. For the second quarter, Bausch Health Companies had an EPS of $1.07, compared to year-ago quarter EPS of $0.93. The stock has a 52-week-high of $28.45 and a 52-week-low of $17.20. Bausch Health Companies's stock last closed at $23.10 per share.
  • Deutsche Bank initiated coverage on Cardinal Health Inc (NYSE: CAH) with a Hold rating. The price target for Cardinal Health is set at $50.00. In the fourth quarter, Cardinal Health showed an EPS of $1.11, compared to $1.01 from the year-ago quarter. The stock has a 52-week-high of $58.31 and a 52-week-low of $41.03. Cardinal Health's stock last closed at $48.89 per share.
  • For CarGurus Inc (NASDAQ: CARG), Needham initiated coverage, by setting the current rating at Hold. CarGurus earned $0.10 in the second quarter, compared to $0.06 in the year-ago quarter. The total market value of CarGurus's outstanding shares is at $4.1 billion. The stock has a 52-week-high of $57.25 and a 52-week-low of $30.22. CarGurus's stock last closed at $35.72 per share.
  • With a rating of Buy, B. Riley FBR initiated coverage on Cypress Energy Partners LP (NYSE: CELP). The price target is set at $11.00 for Cypress Energy Partners. For the second quarter, Cypress Energy Partners had an EPS of $0.29, compared to year-ago quarter EPS of $0.24. The current market cap for Cypress Energy Partners is at $57.9 million. The stock has a 52-week-high of $8.10 and a 52-week-low of $5.36. Cypress Energy Partners's stock last closed at $7.70 per share.
  • Deutsche Bank initiated coverage on Cigna Corp (NYSE: CI) with a Buy rating. The price target for Cigna is set at $207.00. In the second quarter, Cigna showed an EPS of $4.30, compared to $3.89 from the year-ago quarter. The total market value of Cigna's outstanding shares is at $40.0 billion. The stock has a 52-week-high of $226.60 and a 52-week-low of $141.95. Cigna's stock last closed at $161.81 per share.
  • Deutsche Bank initiated coverage on Centene Corp (NYSE: CNC) with a Buy rating. The price target for Centene is set at $62.00. For the second quarter, Centene had an EPS of $1.34, compared to year-ago quarter EPS of $1.80. The current market cap for Centene is at $26.7 billion. The stock has a 52-week-high of $74.49 and a 52-week-low of $44.50. Centene's stock last closed at $46.81 per share.
  • With a rating of Buy, Canaccord Genuity initiated coverage on Coupa Software Inc (NASDAQ: COUP). The price target is set at $171.00 for Coupa Software. In the second quarter, Coupa Software showed an EPS of $0.07, compared to $0.05 from the year-ago quarter. The total market value of Coupa Software's outstanding shares is at $3.5 billion. The stock has a 52-week-high of $156.16 and a 52-week-low of $52.01. Coupa Software's stock last closed at $134.48 per share.
  • Benchmark initiated coverage on Cirrus Logic Inc (NASDAQ: CRUS) with a Buy rating. The price target for Cirrus Logic is set at $62.00. In the first quarter, Cirrus Logic showed an EPS of $0.35, compared to $0.28 from the year-ago quarter. The stock has a 52-week-high of $60.00 and a 52-week-low of $31.25. Cirrus Logic's stock last closed at $55.34 per share.
  • Mizuho initiated coverage on Corvus Pharmaceuticals Inc (NASDAQ: CRVS) with a Buy rating. The price target for Corvus Pharmaceuticals is set at $7.00. Corvus Pharmaceuticals earned ($0.44) in the second quarter, compared to ($0.40) in the year-ago quarter. Corvus Pharmaceuticals's market cap stands at $320.0 million. The stock has a 52-week-high of $10.93 and a 52-week-low of $3.20. Corvus Pharmaceuticals's stock last closed at $4.15 per share.
  • Needham initiated coverage on Carvana Co (NYSE: CVNA) with a Buy rating. The price target for Carvana is set at $105.00. For the second quarter, Carvana had an EPS of ($0.40), compared to year-ago quarter EPS of ($0.37). The total market value of Carvana's outstanding shares is at $10.4 billion. The stock has a 52-week-high of $85.07 and a 52-week-low of $28.44. Carvana's stock last closed at $78.00 per share.
  • Deutsche Bank initiated coverage on CVS Health Corp (NYSE: CVS) with a Buy rating. The price target for CVS Health is set at $91.00. For the second quarter, CVS Health had an EPS of $1.89, compared to year-ago quarter EPS of $1.69. The current market cap for CVS Health is at $56.8 billion. The stock has a 52-week-high of $82.15 and a 52-week-low of $51.72. CVS Health's stock last closed at $64.00 per share.
  • Deutsche Bank initiated coverage on Diplomat Pharmacy Inc (NYSE: DPLO) with a Sell rating. The price target for Diplomat Pharmacy is set at $4.00. In the second quarter, Diplomat Pharmacy showed an EPS of ($0.25), compared to $0.17 from the year-ago quarter. The current market cap for Diplomat Pharmacy is at $2.0 billion. The stock has a 52-week-high of $21.48 and a 52-week-low of $4.17. Diplomat Pharmacy's stock last closed at $6.53 per share.
  • With a rating of Buy, Guggenheim initiated coverage on Emergent BioSolutions Inc (NYSE: EBS). The price target is set at $65.00 for Emergent BioSolutions. Emergent BioSolutions earned ($0.12) in the second quarter, compared to $1.07 in the year-ago quarter. The total market value of Emergent BioSolutions's outstanding shares is at $1.6 billion. The stock has a 52-week-high of $73.89 and a 52-week-low of $39.11. Emergent BioSolutions's stock last closed at $54.40 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on eHealth Inc (NASDAQ: EHTH). The price target is set at $173.00 for eHealth. For the second quarter, eHealth had an EPS of $0.10, compared to year-ago quarter EPS of ($0.40). The stock has a 52-week-high of $112.22 and a 52-week-low of $26.46. eHealth's stock last closed at $73.63 per share.
  • With a rating of Buy, Guggenheim initiated coverage on EyePoint Pharmaceuticals Inc (NASDAQ: EYPT). The price target is set at $4.00 for EyePoint Pharmaceuticals. In the fourth quarter, EyePoint Pharmaceuticals showed an EPS of ($0.11), compared to ($0.62) from the year-ago quarter. EyePoint Pharmaceuticals's market cap stands at \791,421. The stock has a 52-week-high of $3.94 and a 52-week-low of $1.19. EyePoint Pharmaceuticals's stock last closed at $1.60 per share.
  • Canaccord Genuity initiated coverage on Fidelity National Information Services Inc (NYSE: FIS) with a Buy rating. The price target for Fidelity National Info is set at $151.00. Fidelity National Info earned $1.78 in the second quarter, compared to $1.23 in the year-ago quarter. The stock has a 52-week-high of $141.35 and a 52-week-low of $94.53. Fidelity National Info's stock last closed at $131.27 per share.
  • With a rating of Buy, Canaccord Genuity initiated coverage on Fiserv Inc (NASDAQ: FISV). The price target is set at $130.00 for Fiserv. For the second quarter, Fiserv had an EPS of $0.82, compared to year-ago quarter EPS of $0.75. The stock has a 52-week-high of $109.92 and a 52-week-low of $68.45. Fiserv's stock last closed at $102.00 per share.
  • With a rating of Buy, Mizuho initiated coverage on Forty Seven Inc (NASDAQ: FTSV). The price target is set at $18.00 for Forty Seven. In the second quarter, Forty Seven showed an EPS of ($0.74), compared to ($2.52) from the year-ago quarter. The current market cap for Forty Seven is at $519.0 million. The stock has a 52-week-high of $23.83 and a 52-week-low of $6.04. Forty Seven's stock last closed at $8.00 per share.
  • Canaccord Genuity initiated coverage on Green Dot Corp (NYSE: GDOT) with a Hold rating. The price target for Green Dot is set at $29.00. For the second quarter, Green Dot had an EPS of $0.90, compared to year-ago quarter EPS of $0.74. The stock has a 52-week-high of $93.00 and a 52-week-low of $24.19. Green Dot's stock last closed at $28.58 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on HealthEquity Inc (NASDAQ: HQY). The price target is set at $74.00 for HealthEquity. HealthEquity earned $0.45 in the second quarter, compared to $0.34 in the year-ago quarter. The total market value of HealthEquity's outstanding shares is at $4.0 billion. The stock has a 52-week-high of $101.58 and a 52-week-low of $50.29. HealthEquity's stock last closed at $58.61 per share.
  • Deutsche Bank initiated coverage on Humana Inc (NYSE: HUM) with a Hold rating. In the second quarter, Humana showed an EPS of $6.05, compared to $3.96 from the year-ago quarter. Humana's market cap stands at $43.2 billion. The stock has a 52-week-high of $355.88 and a 52-week-low of $225.65. Humana's stock last closed at $276.78 per share.
  • Guggenheim initiated coverage on Horizon Therapeutics PLC (NASDAQ: HZNP) with a Buy rating. The price target for Horizon Therapeutics is set at $36.00. Horizon Therapeutics earned $0.49 in the second quarter, compared to $0.48 in the year-ago quarter. The stock has a 52-week-high of $29.44 and a 52-week-low of $16.56. Horizon Therapeutics's stock last closed at $26.71 per share.
  • BMO Capital initiated coverage on Incyte Corp (NASDAQ: INCY) with a Market Perform rating. The price target for Incyte is set at $85.00. In the second quarter, Incyte showed an EPS of $0.75, compared to $0.26 from the year-ago quarter. The total market value of Incyte's outstanding shares is at $18.0 billion. The stock has a 52-week-high of $89.30 and a 52-week-low of $57.00. Incyte's stock last closed at $78.48 per share.
  • Canaccord Genuity initiated coverage on IHS Markit Ltd (NYSE: INFO) with a Buy rating. The price target for IHS Markit is set at $78.00. For the second quarter, IHS Markit had an EPS of $0.71, compared to year-ago quarter EPS of $0.61. IHS Markit's market cap stands at $24.9 billion. The stock has a 52-week-high of $68.88 and a 52-week-low of $44.52. IHS Markit's stock last closed at $65.60 per share.
  • Deutsche Bank initiated coverage on McKesson Corp (NYSE: MCK) with a Hold rating. The price target for McKesson is set at $155.00. McKesson earned $3.31 in the first quarter, compared to $2.90 in the year-ago quarter. McKesson's market cap stands at $24.3 billion. The stock has a 52-week-high of $150.82 and a 52-week-low of $106.11. McKesson's stock last closed at $148.53 per share.
  • Deutsche Bank initiated coverage on Molina Healthcare Inc (NYSE: MOH) with a Buy rating. The price target for Molina Healthcare is set at $145.00. In the second quarter, Molina Healthcare showed an EPS of $2.96, compared to $2.25 from the year-ago quarter. Molina Healthcare's market cap stands at $7.7 billion. The stock has a 52-week-high of $159.00 and a 52-week-low of $105.28. Molina Healthcare's stock last closed at $118.72 per share.
  • JP Morgan initiated coverage on Insight Enterprises Inc (NASDAQ: NSIT) with an Overweight rating. The price target for Insight Enterprises is set at $68.00. For the second quarter, Insight Enterprises had an EPS of $1.49, compared to year-ago quarter EPS of $1.45. The stock has a 52-week-high of $60.10 and a 52-week-low of $37.77. Insight Enterprises's stock last closed at $50.03 per share.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

 

Related Articles (ABC + ABBV)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
HSKACanaccord GenuityMaintains75.0
AVGOMorgan StanleyMaintains265.0
AMATNeedhamMaintains56.0
VOYACitigroupMaintains62.0
VCCitigroupMaintains86.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Medicine Man Technologies To Buy Edible Maker Canyon LLC For $5.3M

Landstar Guides Lower Due To "Tragic Accident" And Unfavorable Market Conditions